Daniel Virnich - 20 Nov 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Executive Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich
Issuer symbol
TOI
Transactions as of
20 Nov 2024
Net transactions value
-$1,323
Form type
4
Filing time
21 Nov 2024, 18:23:01 UTC
Previous filing
18 Nov 2024
Next filing
20 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Disposed to Issuer $646 -4,750 -0.66% $0.1360 716,961 20 Nov 2024 Direct F1, F2
transaction TOI Common stock Disposed to Issuer $677 -4,977 -0.69% $0.1360 711,984 20 Nov 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.